Purchase Order 75N93020P00739
Award Date 6/18/20
Potential Completion Date 7/24/20
Potential Value $576K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Waltham, MA 02454, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $214,788 firm fixed price purchase order to Nova Biomedical Corporation of Waltham, Massachusetts. The contract is for NOVA Biomedical consumables for the NOVA Flex 2 analytical laboratory instrument, as described in the attached bill of materials, to support the Vaccine Production Program of the Vaccine Research Center. Delivery of the products will occur in...
- The U.S. Department of Health and Human Services, National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm-fixed-price purchase order to Nova Biomedical Corp, a manufacturer of advanced critical care blood gas analyzers, testing meters, and in-vitro diagnostic equipment. The $164,144 contract is for the delivery of various medical consumables over the period ending September 15, 2022. The award resulted from a brand name-restricted, full...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $230,978.00 firm fixed price purchase order to Nova Biomedical Corp for NOVA Biomedical consumables for the NOVA Flex 2 blood gas analyzer. The award originates from a simplified acquisition procedure solicitation issued by the Vaccine Production Program of the Vaccine Research Center (VRC) of NIAID, which sought the supplies without a small business...
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Nova Biomedical Corp, a manufacturer of advanced medical equipment and supplies. The contract, valued at $196,121.36, is for a standing order of Nova Biomedical's laboratory supplies. The period of performance extends through April 23, 2025. Nova Biomedical Corp is a large, privately-owned in vitro diagnostics company that has a history of providing a wide...
- The U.S. Department of Health and Human Services (HHS) awarded a $54,600 firm-fixed-price purchase order to Nova Biomedical Corp, a manufacturer of medical equipment and diagnostics based in Waltham, Massachusetts. The contract is for the provision of FDA-approved Nova Biomedical glucose testing systems to the NIH Clinical Center in Bethesda, Maryland. The award has an ultimate completion date of September 21, 2023 and is not designated as a set-aside contract. Nova Biomedical has an extensive...
- This contract is a Firm Fixed Price Purchase Order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health, to Nova Biomedical Corporation. The contract, valued at $196,121.36, is for the procurement of laboratory supplies and medical equipment, including blood gas analyzers, glucose monitors, and other diagnostic devices. Nova Biomedical is a large, privately-owned manufacturer of critical care medical equipment and in-vitro...
- Nova Biomedical Corporation, a manufacturer of in vitro diagnostic equipment located in Waltham, MA, has been awarded a $12,800 firm fixed price purchase order by the National Institutes of Health Clinical Center. The purchase order does not include any set aside designations. Nova Biomedical will provide unspecified clinical laboratory instruments, reagents, test strips, and associated supplies and services in support of biomedical research activities conducted at the NIH Clinical Center in...
- The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $11,502.40 purchase order to New England Biolabs, Inc. for biological supplies and reagent kits. The firm fixed price order is for the delivery of these products to Ipswich, Massachusetts between August 29 and October 15, 2023. As the prime contractor, New England Biolabs will supply the requested biological supplies and reagents to support the National...
- The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $751,407 purchase order to Becton, Dickinson and Company BD Biosciences, Systems and Reagents Division for FACSymphony S6 analysis systems. The contract is associated with NIH's efforts to support coronavirus COVID-19 research and will provide the analysis systems to support this work. Performance will occur in San Jose, California over a period of...
- The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $206,933 firm fixed price purchase order to Global Life Sciences Solutions USA LLC for an AKTA PILOT 600S chromatography system plus accessories. The prime contractor, Global Life Sciences Solutions USA LLC, is a subsidiary of Danaher Corporation. The place of performance is in Marlborough, Massachusetts. The period of performance is from July 31, 2023...
The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $576,000 firm fixed price purchase order to Nova Biomedical Corporation of Waltham, Massachusetts. The contract calls for COVID-19 related equipment including five BioProfile FLEX2 modules to support the agency's coronavirus response efforts. Performance will occur in Waltham through July 2020. No set aside designation or subcontractors were indicated. This purchase augments NIH-NIAID's ongoing infectious disease research programs through acquisition of biomedical profiling technology for COVID-19 studies during the current public health emergency period.
Generated 12/25/23, 3:21 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Other Administrative Action | $0 | 9/8/20 | |
| Not listed | Not listed | $576.0k | 6/18/20 |